A Win For NLS Pharmaceutics Ltd.
Wed, Jul 26, 2023 at 07:30 PM
NLS Pharmaceutics Ltd. (NLSP:NASDAQ) soared at $1.06, representing a gain of 38.4%. On Wed, Jul 26, 2023, NLSP:NASDAQ hit a New 2-Week High of $1.06. The stock got featured on our News Catalysts scanner on Mon, Jul 03, 2023 at 07:24 AM in the 'BIOTECH' category. From Wed, Jul 12, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jul 05, 2023 at $1.53 with a volume of 1M+.
About NLS Pharmaceutics Ltd. (NLSP:NASDAQ)
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders.
Top 10 Gainers:
- Mallinckrodt plc (MNK:NYSEMKT), 186.36%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 166.67%
- Vicor Corporation (VICR:NASDAQ), 57.72%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- AERWINS Technologies Inc Com (AWIN:NASDAQ), 44.93%
- Tupperware Brands Corporation (TUP:NYSE), 42.86%
- Aceragen Inc Com (ACGN:NASDAQ), 42.06%
- Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 39.09%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 38.41%
- SCWorx Corp. (WORX:NASDAQ), 33.44%